Aduro Biotech Announces Poster Presentations of Phase 2 Pancreatic Cancer and Phase 1B Mesothelioma Clinical Trials at American Society of Clinical Oncology
5/20/2013 7:09:17 AM
More...
|
Aduro Biotech Scientific Advisory Board Member Daniel A. Portnoy Elected to the National Academy of Sciences
5/8/2013 8:01:41 AM
More...
|
Aduro Biotech Announces Collaboration With Johns Hopkins University to Evaluate Aduro Therapeutic Melanoma Vaccines in Combination With Anti-PD-1
4/22/2013 12:54:39 PM
More...
|
Aduro Biotech Announces Upcoming Presentations on Oncology Programs at American Association for Cancer Research Meeting
4/5/2013 6:24:12 AM
More...
|
Aduro Biotech Announces $6.5 Million Financing
1/31/2013 7:28:27 AM
More...
|
Aduro Biotech Announces Two Presentations at Keystone Meeting
12/12/2012 9:22:48 AM
More...
|
Aduro Biotech Announces Completion of Enrollment in Phase 2 Clinical Trial
11/29/2012 9:42:24 AM
More...
|
Aduro Biotech Announces First Patient Enrolled in Mesothelioma Clinical Trial
10/2/2012 9:46:07 AM
More...
|
Novel Malaria Vaccine Collaboration Announced by Protein Potential LLC and Aduro Biotech
9/19/2012 9:24:34 AM
More...
|
Aduro Biotech CDMRP Grant for Prostate Cancer Vaccine Development
9/6/2012 10:21:32 AM
More...
|
|